Table 1 Features of HPV-positive patients enrolled in the randomized study

Number of partecipans

160

Nullipara

60/160 (37.5%)

Pluripara

100/160 (62.5%)

Monogamous heterosexual relationships

124/160 (77.5%)

Same-sex relationships

36/160 (22.5%)

Smoking

72/160 (45%)

Contraceptive pill use

38/160 (23.75%)

Symtoms of vaginosis

43/160 (26.8%)

Age (median-years)

45 (30–64)

Patients with high-risk HPV

105/160 (65%)

High HPV genotype

HPV 16: 29/105 (27.6%)

HPV 18: 17/105 (16.1%)

HPV 66: 13/105 (12.3%)

HPV 68: 15/105 (14.2%)

HPV 58: 10/105 (9.5%)

HPV 45: 18/105 (17.1%)

HPV 53: 12/105 (11.4%)

HPV 51: 18/105 (17.1%)

HPV 52: 17/105 (16.1%)

HPV 35: 18/105 (17.1%)

Patients with concomitant Low risk HPV

55/160 (34%)

Low HPV genotype

HPV 6: 23/55 (41%)

HPV 11: 29/55 (52.7%)

HPV 40: 3/55 (5.3%)